Literature DB >> 7436829

Prognosis in uveal melanoma with extrascleral extension.

J C Affeldt, D S Minckler, S P Azen, L Yeh.   

Abstract

Two thirds of 60 patients followed up after enucleation for uveal melanoma with extrascleral extension eventually died of metastatic disease. Large intraocular tumor size, more malignant cell types, optic nerve invasion, and surgical transection or nonencapsulation of the extraocular tumor margin were found to be significantly correlated with development of metastases. Advanced age at enucleation and large intraocular tumor size were significantly associated with early metastatic death. Recurrence of tumor in the orbit was identified in 10% of the patients and was significantly correlated with large intraocular tumor size and optic nerve invasion. Early exenteration, performed in seven cases, did not improve prognosis. Application of Bayesian methods produced a multifactorial model for prediction of metastatic disease within 13 years after enucleation.

Entities:  

Mesh:

Year:  1980        PMID: 7436829     DOI: 10.1001/archopht.1980.01020040827006

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  20 in total

Review 1.  Retinoinvasive malignant melanoma of the uvea.

Authors:  T Kivelä; P Summanen
Journal:  Br J Ophthalmol       Date:  1997-08       Impact factor: 4.638

2.  Postenucleation orbital radiotherapy for the treatment of malignant melanoma of the choroid with extrascleral extension.

Authors:  P G Hykin; A C McCartney; P N Plowman; J L Hungerford
Journal:  Br J Ophthalmol       Date:  1990-01       Impact factor: 4.638

3.  Clinical Features, Metastasis, and Survival in Patients Younger Than 21 Years With Posterior Uveal Melanoma.

Authors:  Matthew V Fry; James J Augsburger; Zélia M Corrêa
Journal:  JAMA Ophthalmol       Date:  2019-01-01       Impact factor: 7.389

4.  Surgery vs. radiotherapy in patients with uveal melanoma : Analysis of the SEER database using propensity score matching and weighting.

Authors:  Bum-Sup Jang; Ji Hyun Chang; Sohee Oh; Yu Jin Lim; Il Han Kim
Journal:  Strahlenther Onkol       Date:  2017-09-06       Impact factor: 3.621

5.  The biological and prognostic significance of angiotropism in uveal melanoma.

Authors:  Raymond L Barnhill; Mengliang Ye; Aude Batistella; Marc-Henri Stern; Sergio Roman-Roman; Rémi Dendale; Olivier Lantz; Sophie Piperno-Neumann; Laurence Desjardins; Nathalie Cassoux; Claire Lugassy
Journal:  Lab Invest       Date:  2017-02-27       Impact factor: 5.662

6.  Risk factors for metastatic uveal melanoma after trans-scleral local resection.

Authors:  B E Damato; J Paul; W S Foulds
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

7.  M2/M1 ratio of tumor associated macrophages and PPAR-gamma expression in uveal melanomas with class 1 and class 2 molecular profiles.

Authors:  Martina C Herwig; Chris Bergstrom; Jill R Wells; Tobias Höller; Hans E Grossniklaus
Journal:  Exp Eye Res       Date:  2012-11-30       Impact factor: 3.467

8.  CT-scan and intraocular tumours: detection and assessment of size and extrascleral growth of uveal melanomas.

Authors:  R J de Keizer; G J Vielvoye; D de Wolff-Rouendaal
Journal:  Doc Ophthalmol       Date:  1986-01-15       Impact factor: 2.379

9.  Ciliary body melanoma with limited nodular extrascleral extension and diffuse iris-angle infiltration treated by whole anterior segment plaque radiotherapy.

Authors:  Michael E Gray; Zélia M Corrêa; James J Augsburger; William Barrett
Journal:  Int Ophthalmol       Date:  2007-04-28       Impact factor: 2.031

10.  A study of iris melanoma in Northern Ireland.

Authors:  J N McGalliard; P B Johnston
Journal:  Br J Ophthalmol       Date:  1989-08       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.